中文 | English
Return
Total: 90 , 1/9
Show Home Prev Next End page: GO
Author:(Zhongxin LI)

1.The efficacy and safety of high-dose irbesartan in treatment of clinical proteinuria in patients with chronic kidney disease

Xin LI ; Xiangdong CHEN ; Zhongxin LI

Chinese Journal of Internal Medicine 2011;50(12):1034-1038

2.The roles of CD4+CD25+ FOXP3+ regulatory T cells and PD-1+CD4+T cells on prognosis of cervical intraepithelial lesion

Xiuyu LI ; Bo HU ; Zhongxin LI

Chongqing Medicine 2015;(18):2477-2479

3.Molecular targeting therapy of gastric cancer

Denghai MI ; Zhongxin LI ; Ning GAO

Journal of International Oncology 2011;38(5):377-380

4.Surgical treatment of liver adenoma secondary to hepato-glycogenosis

Yanyu LONG ; Jiayu LI ; Zhongxin ZHAO

Chinese Journal of Hepatobiliary Surgery 2010;16(7):552-555

5.Effects of EPO on caspase-9 mRNA expression after globe ischemia-reperfusion in rats

Xiaoying LIN ; Tao HUANG ; Zhongxin LI

Journal of Clinical Neurology 1997;0(06):-

6.The relationship between serum adiponectin level and chronic inflammation,atherosclerosis in maintenance hemodialysis patients.

Zhongxin LI ; Juan MENG ; Liren PENG

Chinese Journal of Practical Internal Medicine 2001;0(10):-

7.Localization and Functional Analysis of SeMNPV IE1 in Mammalian Cells

Xiaowei MEI ; Li YAO ; Zhongxin ZHANG

Virologica Sinica 2010;25(3):183-190

8.Meticillin-resistant Staphylococcus haemolyticus and Resistance in 103 Isolates of S.haemolyticus

Rui LI ; Zizhong XIONG ; Zhongxin WANG

Chinese Journal of Nosocomiology 2009;0(15):-

9.Expression of ERCC-1 protein and its clinical implication in locally advanced cervical cancer

Zhongxin ZHANG ; Wei LI ; Hong SUN

Chinese Journal of Radiation Oncology 2017;26(9):1033-1037

10.The relationship between hyperhomocyseinemia and atherosclerosis in hemodialysis patients

Zhongxin LI ; Yang SHEN ; Liren PENG

Chinese Journal of Practical Internal Medicine 2001;0(10):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 90 , 1/9 Show Home Prev Next End page: GO